Inhibition of PCSK9 improves the development of pulmonary arterial hypertension via down-regulating Notch3 expression
Preprint
- 2 September 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Pulmonary arterial hypertension (PAH) is a fatal disease characterized by continuous constriction and occlusion of small pulmonary arteries (PA), leading to the development of right ventricular failure and death. PCSK9(Proprotein convertase subtilisin/kexin type 9) is a kind of serine protease enzyme that increases low-density lipoprotein cholesterol (LDLC) levels through degrading low-density lipoprotein cholesterol receptors (LDLr). However, whether inhibition of PCSK9 can alleviate PAH has not been reported. Methods and results: We reported that PCSK9 expression was up-regulated in lung tissues of PAH patients. In addition, we used PCSK9 monoclonal antibody subcutaneously to inhibit PCSK9 expression in mice exposed to chronic hypoxia (10%) in combination with SU5416, a VEGF receptor inhibitor. Hypoxia plus SU5416-induced PAH was attenuated in PCSK9 monoclonal antibody-treated mice compared with wild-type mice. PSCK9 inhibited pulmonary vascular remodeling in mice. Moreover, PCSK9 knockdown significantly altered the proliferation and migration of hypoxia-induced PASMCs. We also found that PCSK9 monoclonal antibody inhibited Notch3 expression in vivo and in vitro experiments. Conclusion: Our results suggest that the PCSK9-Notch3 signaling pathway is critical for the proliferation and migration of PASMCs and provides a potential drug target for the treatment of PAH.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of HypercholesterolemiaJournal of Cardiovascular Pharmacology and Therapeutics, 2018
- TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signallingNature Communications, 2017
- PCSK9 knock-out mice are protected from neointimal formation in response to perivascular carotid collar placementAtherosclerosis, 2016
- Cross-talk between LOX-1 and PCSK9 in vascular tissuesCardiovascular Research, 2015
- Notch signalling in smooth muscle cells during development and diseaseCardiovascular Research, 2012
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertensionEuropean Respiratory Journal, 2010
- Notch3 signaling promotes the development of pulmonary arterial hypertensionNature Medicine, 2009
- Proprotein convertase subtilisin/kexin type 9 (PCSK9)Hepatology, 2008
- Bilateral Leg Edema, Obesity, Pulmonary Hypertension, and Obstructive Sleep ApneaArchives of internal medicine (1960), 2000